Instructions for Credit - There is no fee for this activity. In order to receive CME or CE credit, participants must complete the pre-assessment questions, post-assessment, and activity evaluation, online. Participants must also score at least 70% correct on the post-assessment. Certificates will be distributed online at the conclusion of the activity.



Target Audience:
Physicians, physician assistants, nurses, and nurse practitioners involved in the care of patients in the Emergency Department with acute myeloid leukemia.

Learning Objectives:
At the conclusion of this activity, participants will be able to:

  • Identify the clinical signs and symptoms of patients presenting with undiagnosed acute myeloid leukemia
  • Identify complications of acute myeloid leukemia for patients undergoing treatment
  • Understand the ED diagnostic workup and interpretation of the results
  • Understand the importance of early management and referral
  • Understand how to implement communication strategies when referring patients to the treating oncology team
  • Understand the disparities and barriers that exist for patients living with acute myeloid leukemia

Speakers:
Alice S. Mims, MD, MSCR
Acute Leukemia Clinical Section Head
Associate Professor

The James Cancer Hospital
The Ohio State University
Columbus, OH

Caron Campbell, MD, FACEP
Associate Professor of Emergency Medicine
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, NY

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine - Montefiore Medical Center and The Leukemia & Lymphoma Society. Albert Einstein College of Medicine - Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation of Credits
Physicians
Albert Einstein College of Medicine - Montefiore Medical Center designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.5 hours of credit for completing this program.

Nurse Practitioners
American Academy of Nurse Practitioners Certified Program (AANPCP) and the American Association of Nurse Practitioners (AANP) accept AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.

Registered Nurses
Approval for nurses has been obtained by The Leukemia & Lymphoma Society National Office under provider number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.

All continuing education credits are provided free of charge.

Disclosure of Conflicts of Interest:
Before the activity, all faculty and anyone who is in a position to have control over the content of this activity will disclose the existence of any financial interest and/or relationship(s) they might have with any ineligible company* producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speaker's bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted and mitigated by Albert Einstein College of Medicine - Montefiore Medical Center and The Leukemia & Lymphoma Society for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Accredited Providers:
The associates of Albert Einstein College of Medicine - Montefiore Medical Center and The Leukemia & Lymphoma Society, the accredited providers for this activity, do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME/CE activity during the past 24 months.

Faculty Disclosures:
Alice S. Mims, MD, MSCR - Faculty Author/Course Committee has membership on the Advisory Committee for AbbVie, Bristol-Myers Squibb, Daichi Sankyo, Jazz Pharmaceuticals, Kura Oncology, Genentech, Servier Pharmaceuticals and Syndax Pharmaceuticals in the past 24 months
Caron Campbell, MD, FACEP - Faculty Author/Course Committee/Posttest Reviewer has no relevant financial disclosure in the past 24 months with any ineligible company
Caroline Kornhauser, MPH - Planner/Course Committee has no relevant financial disclosure in the past 24 months with any ineligible company
Lauren Berger, MPH - Planner/Course Committee has no relevant financial disclosure in the past 24 months with any ineligible company
Lesley Hoerst, RN - Planner/Course Committee has no relevant financial disclosure in the past 24 months with any ineligible company

Peer Reviewers
This activity has been peer reviewed in its entirety, for bias and objectivity, by reviewers that have no relevant financial relationships in the last 24 months, prior to the activity. The authors of this activity provided educational content and resources in advance, as we requested. All their recommendations for patient care were made based on current science, evidence, and clinical reasoning, while giving a fair and balanced view of unbiased diagnostic and therapeutic options.

Victor Hatcher, PhD - CME Reviewer has no relevant financial disclosure in the past 24 months with any ineligible company
David Esses, MD - Content Validation Reviewer has no relevant financial disclosure in the past 24 months with any ineligible company

Disclaimer:
The information provided in this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition.

Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

System Requirements:
An active internet connection with Web browser is required to view this activity.

Estimated time to complete activity: 1.0 hour
Date of initial release: August 3, 2022
Valid for CME/CE credit through: February 3, 2024

For questions, concerns, or for assistance for people with disabilities or grievances, please contact ProfEducation@LLS.org